This post was originally published on this siteBlueprint Medicines and partner Roche have won FDA approval for RET inhibitor Gavreto to challenge Eli Lilly’s first-to-market Retevmo.

This post was originally published on this siteRoche said Sept. 4 it has received emergency authorization from the FDA for its nasal swab test that detects the flu and COVID-19 and differentiates

This post was originally published on this siteZURICH (Reuters) – Drugmaker Roche (ROG.S) on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug

This post was originally published on this siteRegeneron Pharmaceuticals announced a deal with rival drugmaker Roche Holding to manufacture Regeneron’s experimental Covid-19 antibody

This post was originally published on this siteHere’s what you need to know about the impact of Covid-19 to navigate the markets today. • Pharmaceutical companies Roche and Regeneron

This post was originally published on this siteRoche Holding AG has agreed to help manufacture and distribute a promising investigational drug for Covid-19 being developed by Regeneron

This post was originally published on this siteZURICH (Reuters) – Regeneron and Roche said on Wednesday they will collaborate on an investigational antibody cocktail against COVID-19, with

This post was originally published on this siteRoche’s neuromyelitis optica spectrum disorder (NMOSD) drug Enspryng has scored US Food and Drug Administration (FDA) approval, setting up a

This post was originally published on this siteRoche’s batch of phase 3 tests of its experimental GI drug etrolizumab has not gone to plan, with “mixed results” highlighting a

This post was originally published on this siteRoche Holding AG ROG, -0.27% said Friday that the Food and Drug Administration had approved Evrysdi, a treatment for spinal muscular atrophy in